← Back to Search

Vitamin D Supplement

Almond Milk with Vitamin D for Chronic Kidney Disease

N/A
Waitlist Available
Led By Jeanette Andrade, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 days
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve vitamin D levels in adults with advanced kidney disease using a special form of vitamin D3 in almond milk. The tiny particles help the body absorb the vitamin better, which may also help reduce inflammation. A form of vitamin D3 has been studied for its potential benefits in improving vitamin D levels and reducing inflammation in patients with chronic kidney disease.

Eligible Conditions
  • Chronic Kidney Failure
  • Chronic Kidney Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Vitamin D
Secondary study objectives
C-reactive protein
Calcium
IL-6
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Based on estimated glomerular filtration rate (eGFR) and vitamin D levels, participants will be placed into the nanoparticle group.
Group II: ComparatorActive Control1 Intervention
Based on the estimated glomerular filtration rate (eGFR) and vitamin D levels, participants will be placed into the microparticle group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NanoD4CKD
2023
N/A
~30

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,409 Previous Clinical Trials
767,202 Total Patients Enrolled
Jeanette Andrade, PhDPrincipal InvestigatorUniversity of Florida

Media Library

MicroD4CKD (Vitamin D Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05165173 — N/A
Chronic Kidney Failure Research Study Groups: Comparator, Intervention
Chronic Kidney Failure Clinical Trial 2023: MicroD4CKD Highlights & Side Effects. Trial Name: NCT05165173 — N/A
MicroD4CKD (Vitamin D Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05165173 — N/A
~8 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top